Dr. Freedman on the NCCN Guidelines for Post-Mastectomy Radiation

Video

Laura M. Freedman, MD, assistant professor, director of Radiation Oncology, Sylvester Comprehensive Cancer Center, discusses the revised National Comprehensive Cancer Network (NCCN) guidelines for post-mastectomy radiation given in women who have pathologic T1 and T2 tumors and 1 to 3 positive lymph nodes.

Laura M. Freedman, MD, assistant professor, director of Radiation Oncology, Sylvester Comprehensive Cancer Center, discusses the revised National Comprehensive Cancer Network (NCCN) guidelines for post-mastectomy radiation given in women who have pathologic T1 and T2 tumors and 1 to 3 positive lymph nodes.

It is known that patients with no lymph nodes involved do not derive a benefit from post-mastectomy radiation, although there are exceptions. For example, high-risk patients and those with positive margins and early-stage tumors, typically do not show additional benefit post-mastectomy.

For patients with 4 or more positive nodes, the addition of radiation provides a positive benefit in terms of local recurrence and overall survival. The data on patients with 1 to 3 positive lymph nodes has been more difficult to obtain. The NCCN guidelines will help streamline the use of radiation in what tends to be a more heterogeneous group of patients, explains Freedman.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Video 1 - "HR+/HER2- Early-Stage Breast Cancer: Background and Risk Stratification "
Minesh Mehta, MD
Ruben Olivares, MD